"Receptors, CCR2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
CCR receptors with specificity for CHEMOKINE CCL2 and several other CCL2-related chemokines. They are expressed at high levels in T-LYMPHOCYTES; B-LYMPHOCYTES; MACROPHAGES; BASOPHILS; and NK CELLS.
| Descriptor ID |
D054390
|
| MeSH Number(s) |
D12.776.543.750.695.160.150.200 D12.776.543.750.705.852.125.150.200
|
| Concept/Terms |
Receptors, CCR2- Receptors, CCR2
- MCP-1 Receptor
- MCP 1 Receptor
- Receptor, MCP-1
- MCP-1 Receptors
- MCP 1 Receptors
- Receptors, MCP-1
- Monocyte Chemoattractant Protein 1 Receptor
- CCR2 Receptor
- Receptor, CCR2
- CCR2 Receptors
- CC Chemokine Receptor 2
- CD192 Antigens
- Antigens, CD192
- CC Chemokine Receptor-2
- Chemokine Receptor-2, CC
- Receptor-2, CC Chemokine
- CC Chemokine Receptors 2
CCR2a Receptor- CCR2a Receptor
- Receptor, CCR2a
- MCP-1RA
- CCR-2A MCP-1 Receptor
- CCR 2A MCP 1 Receptor
- MCP-1 Receptor, CCR-2A
- Receptor, CCR-2A MCP-1
- MCP-1 Receptor CCR-2A
- MCP 1 Receptor CCR 2A
- Receptor CCR-2A, MCP-1
CCR2b Receptor- CCR2b Receptor
- Receptor, CCR2b
- MCP-1 Receptor 2B
- MCP 1 Receptor 2B
- CCR2b Receptors
- Receptors, CCR2b
- CC CKR2B
- MCP-1RB
|
Below are MeSH descriptors whose meaning is more general than "Receptors, CCR2".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Chemokine [D12.776.543.750.695.160]
- Receptors, CCR [D12.776.543.750.695.160.150]
- Receptors, CCR2 [D12.776.543.750.695.160.150.200]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Cytokine [D12.776.543.750.705.852]
- Receptors, Chemokine [D12.776.543.750.705.852.125]
- Receptors, CCR [D12.776.543.750.705.852.125.150]
- Receptors, CCR2 [D12.776.543.750.705.852.125.150.200]
Below are MeSH descriptors whose meaning is more specific than "Receptors, CCR2".
This graph shows the total number of publications written about "Receptors, CCR2" by people in this website by year, and whether "Receptors, CCR2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 1 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, CCR2" by people in Profiles.
-
Astrocytic Slc4a4 regulates blood-brain barrier integrity in healthy and stroke brains via a CCL2-CCR2 pathway and NO dysregulation. Cell Rep. 2024 05 28; 43(5):114193.
-
Targeting CCR2+ macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer. J Cancer Res Clin Oncol. 2022 Apr; 148(4):803-821.
-
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy. Commun Biol. 2020 11 27; 3(1):720.
-
MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis. Oncogene. 2020 02; 39(8):1681-1695.
-
Medulloblastoma rendered susceptible to NK-cell attack by TGF? neutralization. J Transl Med. 2019 09 23; 17(1):321.
-
Should we be itching for a CCL2 itch and pain medicine? Brain Behav Immun. 2019 10; 81:12-13.
-
Infiltrating CCR2+ monocytes and their progenies, fibrocytes, contribute to colon fibrosis by inhibiting collagen degradation through the production of TIMP-1. Sci Rep. 2019 06 12; 9(1):8568.
-
The Functional Heterogeneity of Resident Cardiac Macrophages in Myocardial InjuryCCR2+ Cells Promote Inflammation, Whereas CCR2- Cells Protect. Circ Res. 2019 01 18; 124(2):183-185.
-
CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation. Mol Cancer Res. 2019 02; 17(2):604-617.
-
Chemokine CCL2 and its receptor CCR2 in the dorsal root ganglion contribute to oxaliplatin-induced mechanical hypersensitivity. Pain. 2018 Jul; 159(7):1308-1316.